CA Stock MarketDetailed Quotes
CVM CVR Medical Corp
- 0.000
- 0.0000.00%
15min DelayTrading Jul 2 09:30 ET
0Market Cap0.00P/E (TTM)
0.000High0.000Low0Volume0.000Open0.000Pre Close0.00Turnover0.02052wk High0.00%Turnover Ratio107.23MShares0.01552wk Low-0.027EPS TTM0Float Cap7.000Historical High0.00P/E (Static)93.52MShs Float0.015Historical Low-0.025EPS LYR0.00%Amplitude--Dividend TTM0.00P/B1Lot Size--Div YieldTTM
CVR Medical Corp Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | (FY)Dec 31, 2021 | (Q4)Dec 31, 2021 | (Q3)Sep 30, 2021 | (Q2)Jun 30, 2021 | (Q1)Mar 31, 2021 | (FY)Dec 31, 2020 | (Q4)Dec 31, 2020 | (Q3)Sep 30, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | 192.92%108.69K | -55.19%143.43K | 598.21%593.25K | 146.07%210.93K | 2.30%179.2K | -208.85%-116.97K | 23.03%320.09K | -98.29%84.97K | -143.06%-457.85K | -27.17%175.17K |
| Selling and administrative expenses | 192.80%108.69K | -51.09%143.4K | 2,227.00%564.83K | 146.05%210.87K | 6.21%177.89K | -208.03%-117.12K | 42.12%293.19K | -99.16%24.27K | -191.75%-457.93K | 217.78%167.49K |
| -General and administrative expense | 192.80%108.69K | -51.09%143.4K | 2,227.00%564.83K | 146.05%210.87K | 6.21%177.89K | -208.03%-117.12K | 42.12%293.19K | -99.16%24.27K | -191.75%-457.93K | 217.78%167.49K |
| Research and development costs | --0 | --0 | -53.41%28.17K | -126.92%-7 | -83.53%1.26K | 108.59%86 | -50.14%26.83K | -97.10%60.46K | -100.00%26 | -98.01%7.62K |
| Depreciation amortization depletion | --0 | -49.18%31 | 6.90%248 | 3.33%62 | 6.90%62 | 12.50%63 | 5.17%61 | -0.85%232 | 1.69%60 | -1.69%58 |
| -Depreciation and amortization | --0 | -49.18%31 | 6.90%248 | 3.33%62 | 6.90%62 | 12.50%63 | 5.17%61 | -0.85%232 | 1.69%60 | -1.69%58 |
| Operating profit | -192.92%-108.69K | 55.19%-143.43K | -598.21%-593.25K | -146.07%-210.93K | -2.30%-179.2K | 208.85%116.97K | -23.03%-320.09K | 98.29%-84.97K | 143.06%457.85K | 27.17%-175.17K |
| Net non-operating interest income (expenses) | -11.20%-20.14K | -6.84%-19.55K | 2.58%-74.4K | 12.52%-19.12K | 14.65%-18.87K | -94.52%-18.11K | 20.77%-18.3K | 17.21%-76.37K | 2.14%-21.86K | 6.47%-22.1K |
| Non-operating interest expense | 10.30%19.57K | 6.89%19.2K | -1.49%72.86K | -12.25%18.83K | -13.29%18.33K | 98.01%17.74K | -19.84%17.96K | -22.13%73.97K | -7.61%21.46K | -15.25%21.14K |
| Total other finance cost | 54.62%569 | 4.12%354 | -36.19%1.53K | -26.97%287 | -44.41%537 | 5.14%368 | -50.87%340 | -51.48%2.4K | -56.57%393 | 39.19%966 |
| Other net income (expenses) | -226.47%-61.76K | 1,074.43%28.1K | -9,429.93%-1.15M | -400.49%-1.16M | 60.29%-45.45K | 123.15%48.84K | 103.36%2.39K | 80.63%-12.07K | 398.40%384.63K | -1,319.15%-114.47K |
| Gain on sale of security | -188.56%-52.12K | 212.47%37.3K | -60.65%13.43K | -105.20%-22.41K | 69.47%-34.95K | 127.90%58.85K | 116.75%11.94K | -55.20%34.14K | 4,385.49%430.83K | -1,319.15%-114.47K |
| Special income (charges) | 3.68%-9.65K | 3.67%-9.19K | -2,417.93%-1.16M | -2,352.87%-1.13M | ---10.51K | ---10.01K | ---9.54K | 66.64%-46.21K | ---46.21K | --0 |
| -Less:Restructuring and mergern&acquisition | -3.68%9.65K | -3.67%9.19K | -120.24%-9.35K | -185.30%-39.42K | --10.51K | --10.01K | --9.54K | --46.21K | --46.21K | --0 |
| -Less:Impairment of capital assets | ---- | ---- | --1.17M | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| Income before tax | -229.04%-190.59K | 59.86%-134.88K | -948.22%-1.82M | -268.87%-1.39M | 21.88%-243.52K | 145.07%147.7K | 5.23%-335.99K | 96.62%-173.4K | 167.57%820.62K | -14.52%-311.74K |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | -229.04%-190.59K | 59.86%-134.88K | -948.22%-1.82M | -268.87%-1.39M | 21.88%-243.52K | 145.07%147.7K | 5.23%-335.99K | 96.62%-173.4K | 167.57%820.62K | -14.52%-311.74K |
| Net income continuous operations | -229.04%-190.59K | 59.86%-134.88K | -948.22%-1.82M | -268.87%-1.39M | 21.88%-243.52K | 145.07%147.7K | 5.23%-335.99K | 96.62%-173.4K | 167.57%820.62K | -14.52%-311.74K |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -229.04%-190.59K | 59.86%-134.88K | -948.22%-1.82M | -268.87%-1.39M | 21.88%-243.52K | 145.07%147.7K | 5.23%-335.99K | 96.62%-173.4K | 167.57%820.62K | -14.52%-311.74K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -229.04%-190.59K | 59.86%-134.88K | -948.22%-1.82M | -268.87%-1.39M | 21.88%-243.52K | 145.07%147.7K | 5.23%-335.99K | 96.62%-173.4K | 167.57%820.62K | -14.52%-311.74K |
| Diluted earnings per share | -222.92%-0.0018 | 61.32%-0.0013 | -1,069.59%-0.02 | -289.88%-0.0157 | 21.89%-0.0024 | 145.07%0.0015 | 5.23%-0.0033 | 96.58%-0.0017 | 182.90%0.0083 | -14.53%-0.0031 |
| Basic earnings per share | -222.92%-0.0018 | 61.32%-0.0013 | -1,069.59%-0.02 | -294.45%-0.0157 | 21.89%-0.0024 | 145.07%0.0015 | 5.23%-0.0033 | 96.58%-0.0017 | 180.95%0.0081 | -14.53%-0.0031 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Latest Price
%Chg